DNA ploidy cytometry testing for cervical cancer screening in China - Letter

Clinical Cancer Research

Volumn 16, Issue 13, 2010, Pages 3517-

  Garner, David M ^a   Guillaud, Martial D ^a   MacAulay, Calum E ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER SCREENING; CHINA; CYTOLOGY; CYTOMETRY; LETTER; PAPANICOLAOU TEST; PLOIDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; UTERINE CERVIX CANCER;

CHINA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PLOIDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; UTERINE CERVICAL NEOPLASMS;

EID: 77954224783     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1058     Document Type: Letter

References (1)

1. Tong H, Shen R, Wang Z, et al. DNA Ploidy cytometry testing for cervical cancer screening in China (DNACIC Trial): a prospective randomized, controlled trial. Clin Cancer Res 2009;15:6438-45.